Immunosuppressive mechanisms in the microenvironment of malignant pleural effusions

Cancer Detection and Prevention

Volumn 28, Issue 5, 2004, Pages 325-330

  Sikora, Jan J ^a   Dworacki, Grzegorz T ^a   Kaczmarek, Mariusz T ^a   Jenek, Renata E ^a   Zeromski, Jan O ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

IL 10; NMPs; Pleural effusions; sFasL; TGF ; Tumor host interactions

Indexed keywords

CYTOKINE; FAS LIGAND; FASLG PROTEIN, HUMAN; INTERLEUKIN 10; MEMBRANE PROTEIN; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

APOPTOSIS; ARTICLE; BLOOD; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; METABOLISM; NICK END LABELING; PATHOLOGY; PATHOPHYSIOLOGY; PLEURA EFFUSION; T LYMPHOCYTE;

APOPTOSIS; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAS LIGAND PROTEIN; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOSUPPRESSION; IN SITU NICK-END LABELING; INTERLEUKIN-10; MALE; MEMBRANE GLYCOPROTEINS; PLEURAL EFFUSION, MALIGNANT; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 8144221039     PISSN: 0361090X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cdp.2004.04.003     Document Type: Article

References (32)

1. Chicheportiche Y., Bourdon P.R., Xu H., et al. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J. Biol. Chem. 272:1997;32401-32410
2. Goldstein P. Cell death: TRAIL and its receptors. Curr. Biol. 7:1997;750-753
3. Marsters S.A., Sheridan J.P., Pitti R.M., et al. Identification of a ligand for the death-domain-containing receptor Apo-3. Curr. Biol. 8:1998;525-528
4. Tineke C.T.M., Kraan V.D.P., Boeiji L.C.M., et al. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med. 181:1995;775-779
5. Fox F.E., Capocasale R.J., Ford H.C., et al. Transforming growth factor-β inhibits human T-cell proliferation through multiple targets. Lymphokine Cytokine Res. 11:1992;299-305
6. Fiorentino D.F., Zlotnik A., Mosmann T.R., et al. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:1991;3815-3822
7. Lopez D.M., Lopez-Cepero M., Watson G.A., et al. Modulation of the immune system by mammary tumor-derived factors. Cancer Invest. 9:1991;643-653
8. Nagata S., Goldstein P. The Fas death factor. Science. 267:1995;1449-1456
9. de Waal Malefyt R., Yssel H., Roncarolo M.G., et al. Interleukin-10. Curr. Opin. Immunol. 4:1992;314-320
10. Maeda H., Shiraishi A. TGF-beta contributes to the shift toward Th2-type responses through direct and IL-10-mediated pathways in tumor-bearing mice. J. Immunol. 56:1996;73-78
11. Blay J.Y., Voorzanger N., Favrot M., et al. Presence of Epstein-Barr virus viral interleukin-10 in the serum of patients with non-human- immunodeficiency-virus-related diffuse large-cell non-Hodgkin's lymphomas. Blood. 85:1995;2516-2520
12. Chouaib S., Asselin-Paturel C., Mami-Chouaib F., et al. The host-tumor immune conflict: from immunosupression to resistance and destruction. Immunol. Today. 18:1997;493-497
13. Rabinowich H., Reichert T.E., Kashii Y., et al. Lymphocyte apoptosis induced by Fas ligand: expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor associated lymphocytes. J. Clin. Invest. 101:1998;2579-2588
14. Whiteside T.L., Rabinowich H. The role of Fas/FasL in immunosuppression induced by human tumors. Cancer Immunol. Immunother. 46:1998;175-184
15. Reichert T.E., Rabinowich H., Johnson J.T., et al. Immune cells in the tumor microenvironment: mechanisms resposible for signaling and functional defect. J. Immunother. 21:1998;295-306
16. O'Connell J., O'Sullivan G.C., Collins J.K., et al. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J. Exp. Med. 184:1996;1075-1082
17. Solary E., Micheau O., Dimanche-Boitral M.T., et al. The Fas/Fas-ligand system: implications in the antitumor immune response and in the activity of cytotoxic agents. Bull. Cancer. 85:1998;685-694
18. Hughes S.J., Nambu Y., Soldes O.S., et al. Fas/APO-1 (CD95) is not translocated to the cell membrane in esophageal adenocarcinoma. Cancer Res. 57:1977;5571-5578
19. Sikora J., Dworacki G., Żeromski J. Expression of Fas and Fas ligand and apoptosis in tumor-associated lymphocytes and in tumor cells from malignant pleural effusions. Nat. Immun. 16:1998;244-255
20. Arora S., Lapinski P.E., Raghayan M. Use of chimeric proteins to investigate the role of transporter associated with antigen processing (TAP) structural domains in peptide binding and translocation. Proc. Natl. Acad. Sci. U.S.A. 98:2001;7241-7246
21. Karttunen J.T., Lehner P.J., Gupta S.S., et al. Distinct functions and cooperative interaction of the subunits of the transporter associated with antigen processing (TAP). Proc. Natl. Acad. Sci. U.S.A. 98:2001;7431-7436
22. Corrias M.V., Occhino M., Croce M., et al. Lack of HLA-clas I antigens in human neuroblastoma cells: analysis of its relationship to TAP and tapasin expression. Tissue Antigens. 57:2001;110-117
23. Garrido F., Ruiz-Cabello F., Cabrera T., et al. Implications for immunosurveillance of altered HLA class I phenotype in human tumors. Immunol. Today. 18:1997;89-95
24. Chen Y.M., Yang W.K., Whang-Peng J., et al. An analysis of cytokine status in the serum and effusions of patients with tuberculous and lung cancer. Lung Cancer. 31:2001;25-30
25. Cheng D., Lee Y.C., Rogers J.T., et al. Vascular endothelial growth factor level correlates with transforming growth factor-beta isoform levels in pleural effusions. Chest. 118:2000;1747-1753
26. de Visser K.E., Kast W.M. Effects of TGF-β on the immune system: implications for cancer immunotherapy. Lukemia. 13:1999;1188-1199
27. Zeytun A., Hassuneh M., Nagarkatti M., et al. Fas-Fas ligand-based interactions between tumor cells and tumor specific T lymphocytes: a lethal two-way street. Blood. 90:1997;1952-1959
28. Zeitlin S., Parentn A., Silverstain S., et al. Pre-mRNA splicing and the nuclear matrix. Mol. Cell Biol. 7:1987;111-120
29. Pardoll D.M., Vogelstain B., Coffey D.S., et al. A fixed site of DNA replication in eucaryotic cells. Cell. 19:1980;527-536
30. Miller T.E., Beausang L.A., Winchell L.F., et al. Detection of nuclear matrix proteins in serum from cancer patients. Cancer Res. 52:1992;422-427
31. Merogi A.J., Marrogi A.J., Ramesh R., et al. Tumor-host interaction: analysis of cytokines, growth factors and tumor infiltrating lymphocytes in ovarian carcinomas. Hum Pathol. 28:1997;321-331
32. Morisaki T., Katano M., Ikubo A., et al. Immunosupressive cytokines (IL-10, TGF-β) genes expression in human gastric carcinoma tissues. J. Surg. Oncol. 63:1996;234-239